Sleep & Circadian Research

Sleep architecture, slow-wave sleep, circadian signalling, and related polysomnographic endpoints.

Often described colloquially as “Sleep optimisation”. We use research terminology because the colloquial phrasing implies an outcome the evidence often does not support.

1 graded claim1 with human evidence1 compound

Compounds

Examined in this research area

XInsufficient / conflicting

DSIP

The name is considerably stronger than the evidence. The published sleep findings are old, small, and inconsistent.

Evidence

Claims in this area, strongest first

Ordered by evidence level so that the state of the field is visible at a glance rather than buried.

DSIP

XInsufficient / conflictingVery low confidenceHuman evidence

Historical human studies of DSIP and sleep architecture produced inconsistent findings.

What is not established

Small, dated, inconsistent studies. The compound's name is not an evidence claim.

Supporting sources (1)

Case seriesHumanNo verified identifier on file

Delta sleep-inducing peptide in sleep research

Multiple · Sleep and neuroscience literature · 1990

Population: Small human cohorts, chiefly from the 1970s–1990s
Endpoint: Sleep architecture, latency, and subjective sleep quality
Route: Intravenous in most of the reported work
Quantity as reported: Reported in the historical literature
Frequency: Varies

Result. Findings across the small historical studies are inconsistent.

Adverse events. Not systematically characterised.

Limitations. Old, small, methodologically dated studies with inconsistent results. The name overstates the strength of the sleep evidence.

Search PubMed for this literature →

Last evidence review: 2026-08-23